STOCK TITAN

P10 Announces Full Exercise of Underwriters’ Overallotment Option to Purchase Additional Shares

Rhea-AI Impact
(Neutral)
Rhea-AI Sentiment
(Neutral)
Tags
Rhea-AI Summary

P10, Inc. (NYSE: PX) announced that underwriters of its public offering have fully exercised an option to acquire an additional 3 million shares of Class A common stock at $12 per share. The shares are being sold by certain shareholders, and P10 will not receive any proceeds from this sale. The registration statement was effective as of October 20, 2021. P10 is a multi-asset class private markets solutions provider, with over 2,400 investors globally, servicing large pension funds and financial institutions.

Positive
  • Underwriters fully exercised their option for 3 million additional shares.
  • Class A common stock offered at $12 per share, indicating strong demand.
Negative
  • P10 will not receive any proceeds from the additional share sale.

DALLAS, Nov. 19, 2021 (GLOBE NEWSWIRE) -- P10, Inc. (NYSE: PX), a leading private markets solutions provider, today announced that the underwriters of its previously announced public offering have fully exercised their option to acquire an additional 3,000,000 shares of Class A common stock at the public offering price of $12 per share, less underwriting discounts and commissions. These shares are being sold by certain stockholders of P10 and P10 will not receive any proceeds from the sale.

A registration statement on Form S-1 relating to the offering was declared effective by the Securities and Exchange Commission on October 20, 2021. Copies of the final prospectus related to the offering may be obtained from: Morgan Stanley & Co. LLC, Attention: Prospectus Department, 180 Varick Street, 2nd Floor, New York, NY 10014; J.P. Morgan Securities LLC, c/o Broadridge Financial Solutions, 1155 Long Island Avenue, Edgewood, NY 11717, by telephone at (866) 803-9204, or by email at prospectus-eq_fi@jpmchase.com; Barclays Capital Inc., c/o Broadridge Financial Solutions, 1155 Long Island Avenue, Edgewood, NY 11717 or by email at barclaysprospectus@broadridge.com or by telephone at 1-888-603-5847.

This press release shall not constitute an offer to sell or the solicitation of an offer to buy any securities, and shall not constitute an offer, solicitation, or sale in any jurisdiction in which such offer, solicitation, or sale would be unlawful prior to registration or qualification under the securities laws of that jurisdiction. Any offers, solicitations or offers to buy, or any sales of securities will be made in accordance with the registration requirements of the Securities Act of 1933, as amended.

About P10

P10 is a leading multi-asset class private markets solutions provider in the alternative asset management industry. P10’s mission is to provide its investors differentiated access to a broad set of investment solutions that address their diverse investment needs within private markets. As of September 30, 2021, P10 has a global investor base of over 2,400 investors across 46 states, 29 countries and six continents, which includes some of the world’s largest pension funds, endowments, foundations, corporate pensions and financial institutions. Visit www.p10alts.com.

Ownership Limitations

P10’s Certificate of Incorporation contains certain provisions for the protection of tax benefits relating to P10’s net operating losses. Such provisions generally void transfers of shares that would result in the creation of a new 4.99% shareholder or result in an existing 4.99% shareholder acquiring additional shares of P10.


FAQ

What was announced by P10, Inc. on November 19, 2021?

P10 announced that underwriters fully exercised their option for an additional 3 million shares at $12 per share.

What is the significance of the public offering by P10 on November 19, 2021?

The public offering indicates strong demand for shares, with underwriters acquiring additional shares.

How many shares did the underwriters acquire from P10 in the recent offering?

The underwriters acquired an additional 3 million shares of Class A common stock.

Did P10 receive any proceeds from the additional share sale?

No, P10 will not receive any proceeds from the sale of the additional shares.

What is the public offering price for P10's additional shares?

The public offering price for the additional shares is $12 per share.

P10, Inc.

NYSE:PX

PX Rankings

PX Latest News

PX Stock Data

1.44B
46.50M
16.7%
71.8%
1.73%
Asset Management
Investment Advice
Link
United States of America
DALLAS